Pilot to streamline international inspections

The European Directorate for the Quality of Medicines has established bilateral confidentiality agreements with the U.S. FDA and the Australian Therapeutic Goods Administration to share information regarding inspections of active pharmaceutical ingredients (API) and excipients manufacturers. The three organizations are involved in a pilot project to rationalize international good manufacturing practices (GMP) inspections. Release

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.